CyberKnife® enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures

Journal of Hematology and Oncology

Volumn 3, Issue , 2010, Pages

  Oermann, Eric ^a   Collins, Brian T ^a   Erickson, Kelly T ^a   Yu, Xia ^a   Lei, Sue ^a   Suy, Simeng ^a   Hanscom, Heather N ^a   Kim, Joy ^a   Park, Hyeon U ^a   Eldabh, Andrew ^a   Kalhorn, Christopher ^a   McGrail, Kevin ^a   Subramaniam, Deepa ^a   Jean, Walter C ^a   Collins, Sean P ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; CYBERKNIFE; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE FRACTIONATION; RADIATION SAFETY; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; ADOLESCENT; BRAIN TUMOR; COMPUTER ASSISTED RADIOTHERAPY; GLIOMA; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION DOSE; RADIOSURGERY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77953222810     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-3-22     Document Type: Article

References (31)

1. Cancer statistics, 2009. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun, CA Cancer J Clin 2009 59 4 225 49 10.3322/caac.20006 19474385
2. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. KE Wallner JH Galicich G Krol E Arbit MG Malkin, Int J Radiat Oncol Biol Phys 1989 16 6 1405 9 2542195
3. Chemoradiotherapy in malignant glioma: standard of care and future directions. R Stupp ME Hegi MR Gilbert A Chakravarti, J Clin Oncol 2007 25 26 4127 36 10.1200/JCO.2007.11.8554 17827463
4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. R Stupp ME Hegi WP Mason MJ van den Bent MJ Taphoorn RC Janzer SK Ludwin A Allgeier B Fisher K Belanger P Hau AA Brandes J Gijtenbeek C Marosi CJ Vecht K Mokhtari P Wesseling S Villa E Eisenhauer T Gorlia M Weller D Lacombe JG Cairncross RO Mirimanoff European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group, Lancet Oncol 2009 10 5 459 66 10.1016/S1470-2045(09)70025-7 19269895
5. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. MD Prados W Seiferheld HM Sandler JC Buckner T Phillips C Schultz R Urtasun R Davis P Gutin TL Cascino HS Greenberg WJ Curran Jr, Int J Radiat Oncol Biol Phys 2004 58 4 1147 52 15001257
6. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. MJ van den Bent AF Carpentier AA Brandes M Sanson MJ Taphoorn HJ Bernsen M Frenay CC Tijssen W Grisold L Sipos H Haaxma-Reiche JM Kros MC van Kouwenhoven CJ Vecht A Allgeier D Lacombe T Gorlia, J Clin Oncol 2006 24 18 2715 22 10.1200/JCO.2005.04.6078 16782911
7. Central Nervous System Cancers. NCCN Clinical Practice Guideline in Oncology, 2009 3
8. The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. OM Salazar P Rubin, Int J Radiat Oncol Biol Phys 1976 1 7-8 627 37 185169
9. Radiation Dose-Volume Effects in the Brain. YR Lawrence XA Li I el Naqa CA Hahn LB Marks TE Merchant AP Dicker, Int J Radiat Oncol Biol Phys 2010 76 3 Suppl 20 7 20171513
10. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme. NS Floyd SY Woo BS Teh C Prado WY Mai T Trask PL Gildenberg P Holoye ME Augspurger LS Carpenter HH Lu JK Chiu WH Grant EB Butler, Int J Radiat Oncol Biol Phys 2004 58 3 721 6 14967426
11. Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: a multicenter experience. AT Villavicencio S Burneikien P Romanelli L Fariselli L McNeely JD Lipani SD Chang EL Nelson M McIntyre G Broggi JR Adler Jr, Neurosurg Rev 2009 19633875
12. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. L Souhami W Seiferheld D Brachman EB Podgorsak M Werner-Wasik R Lustig CJ Schultz W Sause P Okunieff J Buckner L Zamorano MP Mehta WJ Curran Jr, Int J Radiat Oncol Biol Phys 2004 60 3 853 60 15465203
13. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. R Cardinale M Won A Choucair M Gillin A Chakravarti C Schultz L Souhami A Chen H Pham M Mehta, Int J Radiat Oncol Biol Phys 2006 1; 65 5 1422 8
14. Cone beam CT image guidance for intracranial stereotactic treatments: comparison with a frame guided set-up. L Masi F Casamassima C Polli C Menichelli I Bonucci C Cavedon, Int J Radiat Oncol Biol Phys 2008 71 3 926 33 18514784
15. Technological advances in radiation oncology for central nervous system tumors. SE Noda T Lautenschlaeger MR Siedow DR Patel A El-Jawahri Y Suzuki JS Loeffler MR Bussiere A Chakravarti, Semin Radiat Oncol 2009 19 3 179 86 10.1016/j.semradonc.2009.02.006 19464633
16. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. MD Walker TA Strike GE Sheline, Int J Radiat Oncol Biol Phys 1979 5 1725 31 231022
17. CyberKnife radiosurgery in the treatment of complex skull base tumors: analysis of treatment planning parameters. SP Collins ND Coppa Y Zhang BT Collins DA McRae WC Jean, Radiat Oncol 2006 1 46 10.1186/1748-717X-1-46 17173702
18. Treatment of malignant tumors of the skull base with multi-session radiosurgery. ND Coppa DM Raper Y Zhang BT Collins KW Harter GJ Gagnon SP Collins WC Jean, J Hematol Oncol 2009 2 16 10.1186/1756-8722-2-16 19341478
19. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. CB Scott C Scarantino R Urtasun B Movsas CU Jones JR Simpson AJ Fischbach WJ Curran Jr, Int J Radiat Oncol Biol Phys 1998 40 1 51 5 9422557
20. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. WJ Curran Jr CB Scott J Horton JS Nelson AS Weinstein AJ Fischbach CH Chang M Rotman SO Asbell RE Krisch, et al. J Natl Cancer Inst 1993 85 9 704 10 10.1093/jnci/85.9.704 8478956
21. A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. I Paddick, J Neurosurg 2000 93 Suppl 3 219 22 11143252
22. Dose conformity of gamma knife radiosurgery and risk factors for complications. JL Nakamura LJ Verhey V Smith PL Petti KR Lamborn DA Larson WM Wara MW McDermott PK Sneed, Int J Radiat Oncol Biol Phys 2001 51 5 1313 9 11728692
23. Performance evaluation of a CyberKnife G4 image-guided robotic stereotactic radiosurgery system. C Antypas E Pantelis, Phys Med Biol 2008 53 17 4697 718 10.1088/0031-9155/53/17/016 18695294
24. Patterns of patient movement during frameless image-guided radiosurgery. MJ Murphy SD Chang IC Gibbs QT Le J Hai D Kim DP Martin JR Adler Jr, Int J Radiat Oncol Biol Phys 2003 55 5 1400 8 12654453
25. Common Terminology Criteria for Adverse Events, Version 3.0. CTE Program, DCTD N, NIH, DHHS 2006
26. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. JL Chan SW Lee BA Fraass DP Normolle HS Greenberg LR Junck SS Gebarski HM Sandler, J Clin Oncol 2002 20 6 1635 42 10.1200/JCO.20.6.1635 11896114
27. Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results. A Narayana J Yamada S Berry P Shah M Hunt PH Gutin SA Leibel, Int J Radiat Oncol Biol Phys 2006 64 3 892 7 16458777
28. Image-guided robotic radiosurgery. JR Adler Jr MJ Murphy SD Chang SL Hancock, Neurosurgery 1999 44 1299 1306 discussion 1306-1297 10.1097/00006123-199906000-00079 10371630
29. An anthropomorphic phantom study of the accuracy of Cyberknife spinal radiosurgery. C Yu W Main D Taylor G Kuduvalli ML Apuzzo JR Adler Jr, Neurosurgery 2004 55 1138 1149 10.1227/01.NEU.0000141080.54647.11 15509320
30. Staged stereotactic irradiation for acoustic neuroma. SD Chang IC Gibbs GT Sakamoto E Lee A Oyelese JR Adler Jr, Neurosurgery 2005 56 1254 1261 discussion 1261-1253 10.1227/01.NEU.0000159650.79833.2B 15918941
31. An analysis of the accuracy of the CyberKnife: a robotic frameless stereotactic radiosurgical system. SD Chang W Main DP Martin IC Gibbs MP Heilbrun, Neurosurgery 2003 52 140 146 discussion 146-147. 10.1097/00006123- 200301000-00018 12493111